UnitedHealth Group reports Q3 2026 earnings beat and lifts full‑year profit outlook

UnitedHealth Group posted third‑quarter 2026 results on October 13, showing adjusted earnings of $4.69 per share and revenue of $112.7 billion, a slight decline year‑over‑year. The medical care ratio improved to 88.4% from 89.9% and the operating cost ratio fell to 12.8% from 13.5%. The company raised its full‑year 2026 adjusted earnings guidance to at least $20.50 per share, up from the prior $19.50‑$20 range.

The earnings beat and higher guidance suggest stronger cost control and margin expansion, which could support a higher valuation for UNH shares (the company expects at least $20.50 EPS for FY 2026, per the press release). The guidance lift also implies analysts may revise price targets upward.

Sources